Tumour uptake of the radiolabelled somatostatin analogue [DOTA0,TYR3]octreotide is dependent on the peptide amount

1999-07-29

Additional Metadata
Keywords	[DOTA0, Try3]octreotide, Peptide mass, Somatostatin receptors, Tumour uptake
Persistent URL	doi.org/10.1007/s002590050439, hdl.handle.net/1765/65252
Journal	European Journal of Nuclear Medicine
Organisation	Department of Internal Medicine
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Jong, M., Breeman, W., Bernard, B., van Gameren, A., Bruin, E., Bakker, W., van der Pluijm, M., Visser, T., Mäcke, H.& Krenning, E. (1999). Tumour uptake of the radiolabelled somatostatin analogue [DOTA0,TYR3]octreotide is dependent on the peptide amount. European Journal of Nuclear Medicine, 26(7), 693–698.https://doi.org/10.1007/s002590050439

Publication